novarti
hit
acquisit
trail
swiss
drugmak
novarti
ha
announc
bn
euro
bn
â£bn
of
purchas
to
make
it
sandoz
unit
the
world
biggest
gener
drug
produc
novarti
which
last
month
forecast
record
sale
for
said
it
had
bought
all
of
germani
hexal
it
also
acquir
of
hexal
u
affili
eon
lab
and
offer
to
buy
the
remain
share
for
each
novarti
said
that
it
would
be
abl
to
make
cost
save
of
about
m
a
year
follow
the
acquisit
novarti
share
rose
to
swiss
franc
in
earli
trade
the
deal
will
see
novarti
sandoz
busi
overtak
israel
teva
pharmaceut
a
the
world
biggest
maker
of
gener
base
on
figur
the
newli
merg
produc
would
have
sale
of
more
than
bn
the
compani
estim
novarti
said
that
it
would
merg
a
number
of
depart
ad
that
there
may
be
job
cut
the
strong
growth
outlook
for
sandoz
which
will
creat
job
is
expect
to
partial
compens
for
necessari
reduct
in
the
work
forc
the
firm
said
in
a
statement
gener
drug
are
chemic
ident
to
their
more
expens
brand
rival
produc
such
a
sandoz
can
copi
the
brand
product
usual
after
their
patent
protect
expir
and
can
sell
them
more
cheapli
a
they
do
not
have
to
pay
research
and
develop
cost
there
are
more
than
gener
drugmak
worldwid
and
analyst
have
predict
consolid
in
a
market
that
they
call
fragment
howev
not
all
analyst
were
initi
convinc
about
the
deal
thi
is
a
veri
expens
acquisit
birgit
kuhlhoff
from
sal
oppenheim
invest
bank
told
reuter
i
find
it
strang
that
they
are
make
acquisit
in
exactli
those
market
where
they
suffer
price
pressur
